Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. W. Slaton
WL-276, an Antagonist Against BCL-2 Proteins, Overcomes Drug Resistance and Suppresses Prostate Tumor Growth
Cancer Research
Cancer Research
Oncology
Related publications
Contribution of BCL-2 Phosphorylation to Bak Binding and Drug Resistance
Cancer Research
Cancer Research
Oncology
ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Targeting CD47/TNFAIP8 by miR-155 Overcomes Drug Resistance and Inhibits Tumor Growth Through Induction of Phagocytosis and Apoptosis in Multiple Myeloma
Haematologica
Hematology
Gambogic Acid Inhibits Growth, Induces Apoptosis, and Overcomes Drug Resistance in Human Colorectal Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
Lentiviral Vector Neutral Endopeptidase Gene Transfer Suppresses Prostate Cancer Tumor Growth
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Structure-Activity Relationship Studies of Ethyl 2-Amino-6-Bromo-4-(1-Cyano-2-Ethoxy-2-Oxoethyl)-4h-Chromene-3-Carboxylate (HA 14-1), an Antagonist for Antiapoptotic BCL-2 Proteins to Overcome Drug Resistance in Cancer
AB065. EP4 Antagonist Suppresses Bone Metastasis in Prostate Cancer
Translational Andrology and Urology
Reproductive Medicine
Urology
CDK7 Inhibition Suppresses Aberrant Hedgehog Pathway and Overcomes Resistance to Smoothened Antagonists
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
PDCD4 Is an Androgen-Repressed Tumor Suppressor That Regulates Prostate Cancer Growth and Castration Resistance
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
